Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
NCT:NCT07548164 · RECRUITING
廣告
NCT IDNCT07548164
狀態RECRUITING
開始日期2026-04-16
完成時間2029-04-16
SponsorMemorial Sloan Kettering Cancer Center (OTHER)
First posted
Last updated
簡要摘要
In this study the investigators will find out whether the use of a new type of boost approach called irreversible electroporation (IRE) is as effective as the standard boost approach of radiation therapy for participants with intermediate-risk prostate cancer receiving standard stereotactic body radiotherapy (SBRT).
官方來源
在 ClinicalTrials.gov 上查看 →資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。